The Present and FutureState-of-the-Art ReviewEmergence of Nonobstructive Coronary Artery Disease: A Woman’s Problem and Need for Change in Definition on Angiography
Key Words
Abbreviations and Acronyms
Cited by (0)
This work was supported by contracts N01-HV-68161, N01-HV-68162, N01-HV-68163, N01-HV-68164 from the National Heart, Lung, and Blood Institutes; grants U0164829, U01 HL649141, U01 HL649241, K23HL105787, T32HL69751, R01 HL090957, 1R03AG032631 from the National Institute on Aging; GCRC grant MO1-RR00425 from the National Center for Research Resources; the National Center for Advancing Translational Sciences Grants UL1TR000124 and UL1TR000064; and grants from the Gustavus and Louis Pfeiffer Research Foundation, Danville, NJ; The Women’s Guild of Cedars-Sinai Medical Center, Los Angeles; The Ladies Hospital Aid Society of Western Pennsylvania, Pittsburgh, PA; QMED, Inc., Laurence Harbor, NJ; the Edythe L. Broad and the Constance Austin Women’s Heart Research Fellowships; Cedars-Sinai Medical Center, Los Angeles; the Barbra Streisand Women’s Cardiovascular Research and Education Program, Cedars-Sinai Medical Center, Los Angeles; The Society for Women’s Health Research (SWHR), Washington, D.C.; The Linda Joy Pollin Women’s Heart Health Program; and the Erika Glazer Women’s Heart Health Project, Cedars-Sinai Medical Center, Los Angeles, California. Dr. Light-McGroary is the principal investigator for several multicenter, pharmaceutical clinical trials in heart failure and pulmonary hypertension. Dr. Shah holds equity in Gilead Sciences. Dr. Bairey Merz has received lecture fees from consulting fees from Amgen, Medscape, Pfizer, and has served on the grand review committee for Gilead. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.